Herbalife nutritional products and liver injury revisited

Journal of Hepatology

Volumn 49, Issue 2, 2008, Pages 291-293

  Ignarro, Louis ^a   Heber, David ^a   Henig, Y Steven ^b   Bejar, Ezra ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Herbalife International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; NON PRESCRIPTION DRUG; PARACETAMOL;

COMORBIDITY; HEALTH SURVEY; HUMAN; IDIOPATHIC DISEASE; LETTER; LIVER DISEASE; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; NUTRITIONAL HEALTH; PRIORITY JOURNAL;

DIETARY SUPPLEMENTS; EPHEDRA; HEPATITIS, TOXIC; HUMANS; RISK FACTORS;

EID: 46149126145     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.05.005     Document Type: Letter

References (6)

1. Elinav E., Pinsker G., Safadi R., Pappo O., Bromberg M., Anis E., et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 47 (2007) 514-520
2. Schoepfer A.M., Engel A., Fattinger K., Marbet U.A., Criblez D., Reichen J., et al. Herbal does not mean innocuous: 10 cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 47 (2007) 521-526
3. Stickel F. Slimming at all costs: Herbalife-induced liver injury. J Hepatol 47 (2007) 444-446
4. Gunawan B., and Kaplowitz N. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev 36 (2004) 301-312
5. Bower W.A., Johns M., Margolis H.S., Williams I.T., and Bell B.P. Population-based surveillance for acute liver failure. Am J Gastroenterol 102 (2007) 2459-2463
6. Walker A.M., and Cavanaugh R.J. The occurrence of new hepatic disorders in a defined population. Post Marketing Surveillance 6 (1992) 107-117